|
Symbol
|
RMAFFV | RMAHIV | OTSRCH | OVLRCH | AAYMTQ | RMA9EV | RMBPAV | RMASDV | RMBQSV | ABKBTQ | PHKRCH | RMADDV | RMAH4V | RMBHZV | PMXRCH | RMA3WV | RMBSMV | PSNRCH | MBSXJB | PTDRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Underlying
|
Alcon / Galderma Group AG / Sandoz Group AG | Estée Lauder Co. Inc. / Galderma Group AG / L'Oréal S.A. / UNILEVER TMICC BASKET | Bachem Hldg. AG / Galderma Group AG / Sandoz Group AG | Galderma Group AG / Roche AG / Straumann Hldg. AG | Bachem Hldg. AG / Galderma Group AG / Straumann Hldg. AG | Douglas Hldg. AG / Galderma Group AG / UNILEVER TMICC BASKET | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / Sanofi S.A. | Galderma Group AG / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Galderma Group AG / Givaudan / Straumann Hldg. AG | DOCMORRIS AG / Galderma Group AG / Sandoz Group AG | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | Galderma Group AG / ON Holding AG. / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Novartis AG | Galderma Group AG / Givaudan / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Sandoz Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
29.06.2026 | 24.02.2026 | 02.03.2026 | 13.03.2026 | 20.03.2026 | 28.09.2026 | 27.04.2026 | 11.05.2026 | 18.05.2026 | 12.11.2026 | 02.09.2026 | 05.01.2027 | 10.07.2026 | 17.07.2026 | 24.07.2026 | 17.07.2026 | 07.08.2026 | 03.12.2026 | 11.03.2026 | 03.06.2026 |
| Bid | - | 86.30 | 66.34 | 98.57 | - | 71.80 | 58.00 | 84.10 | 33.900 | - | 89.39 | 100.40 | - | 68.40 | 58.58 | 96.40 | 85.20 | - | - | 101.13 |
| Ask | - | - | 80.00 | 99.37 | - | - | - | - | - | - | - | 101.20 | - | - | - | 97.20 | 86.00 | - | - | - |